ASEAN's healthcare digitalisation is a structural transformation β not a trend. 650M people, government mandates, and a hospital group structure that makes winner-takes-most outcomes possible.
Sources: Frost & Sullivan ASEAN Digital Health Report 2023, WHO SEARO, IFC Private Healthcare in ASEAN analysis.
Total digital health market across Southeast Asia by 2030. Includes EHR, telehealth, AI diagnostics, and hospital operational software.
Hospital workflow automation, AI triage, and patient experience software in ASEAN. The specific segment MOVO-X owns end-to-end.
Malaysia + Singapore + Canada + Indonesia β first 500 hospitals by Year 5. Conservative based on KPJ + IHH + Raffles contracted ARR at full deployment.
Six structural advantages that would be impossible to manufacture β they are properties of the market itself.
650M people, growing middle class, rising private healthcare spend. Unlike the US β where Epic dominates every major health system β ASEAN's hospital OS layer is completely empty. No incumbent to displace. Just a gap to fill.
KPJ = 30+ hospitals. IHH = 80+. Columbia Asia = 20+. One enterprise contract equals massive deployment scale. MOVO-X sells to the group CFO once and activates every hospital. No individual hospital sales required.
MOH Malaysia 2027 framework. Singapore NEHR mandate (private hospitals, effective 2025). Canada OHIP digital integration. Regulatory tailwind is not optional β hospital groups must digitise or face compliance consequences.
ASEAN hospital groups operate in 3β7 languages. MOVO-X supports 7 from launch (EN, MS, ZH, TA, FR, ID, TH). Competitors cannot bolt this on retroactively β it requires architectural decisions made at day zero.
Malaysia and Singapore attract 2M+ medical tourists per year. MOVO-X's English-first kiosk serves international patients natively β national ID scan accepts passports, and UI adapts to the patient's preferred language instantly.
ASEAN hospital groups actively want technology to reduce front-desk headcount. ROI is immediate and calculable: a 15-minute manual check-in process becomes under 3 seconds. The business case writes itself.
No existing competitor has built what MOVO-X has already shipped. The table below reflects current production capabilities β not roadmap.
The window closes when a well-funded competitor builds what we've already built. We have 18 months. The regulatory moat, clinical data flywheel, and group-level contracts compound with every hospital added.
Land-and-expand at the hospital group level. Each group closed increases the value of MOVO-X for the next β compliance playbooks, HIS integrations, and clinical routing data compound across the network.
Malaysia's largest private hospital group. First enterprise contract. Proof point for the entire category.
Fortis (India), ParkwayHealth (SG), Acibadem (Turkey). KPJ reference opens the board-level conversation.
Singapore + China. Natural close with Singapore deployment already in progress.
Malaysia + India + Vietnam. Shared KPJ investor base creates warm introduction path.
Thailand market entry. Combined regional footprint makes this the single largest deployment opportunity.
Network effect: each hospital group closed increases the value of the MOVO-X network for the next. The clinical routing data, compliance playbooks, and HIS integrations compound with every new group.
This is not a product window β it is a regulatory and network-effect window. The compliance moat locks in. The winner will be determined by 2029.
MOH Malaysia issues Healthcare Digitalisation Framework
Singapore NEHR private hospital mandate takes effect
MOVO-X live at KPJ + Canada + Singapore. Series A raising.
MOH Malaysia 2027 compliance deadline. All hospital groups require a platform.
First underfunded ASEAN health tech competitor raises Series B and copies surface features.
Compliance moat locked in. Winner determined. MOVO-X at 500+ hospitals or someone else is.
We're raising our Series A to accelerate from KPJ Healthcare (30+ hospitals) to IHH Healthcare (80+ hospitals across 11 countries) and the full ASEAN private hospital market. The MOH Malaysia 2027 deadline creates a hard forcing function for every hospital group in Malaysia.